The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real-world biomarker testing patterns, first line treatment and drivers of treatment choice in patients with advanced/metastatic gastric/gastroesophageal junction adenocarcinoma in the United States and Europe.
 
Florian Lordick
Honoraria - Art Tempi; Astellas Pharma; AstraZeneca; BioNTech; Bristol-Myers Squibb; Daiichi Sankyo Europe GmbH; Falk Foundation; Incyte; Lilly; Medscape; Medupdate; Merck KGaA; Merck Sharp & Dohme; Novartis; Roche; SERVIER; Streamedup!
Consulting or Advisory Role - Astellas Pharma; Boehringer Ingelheim; Bristol-Myers Squibb; Daichi Sankyo; Merck Sharp & Dohme; PAGE
Research Funding - Gilead Sciences (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Lilly
 
Naureen Starling
Honoraria - Astellas Pharma; AstraZeneca; BMS; BMS; Daiichi Sankyo; GlaxoSmithKline; Merck; Merck Serono; MSD Oncology; MSD Oncology; MSD Oncology; MSD Oncology; Natera; Pierre Fabre; Pierre Fabre; Pierre Fabre; Seagen; SERVIER; SERVIER; SERVIER; Tempus
Consulting or Advisory Role - AstraZeneca; Bristol Myers Squibb; Gilead Sciences; GlaxoSmithKline; Janssen; Moderna Therapeutics; MSD Oncology; Seagen; Takeda
Research Funding - Gilead Sciences (Inst)
Travel, Accommodations, Expenses - Bristol Myers Squibb; GlaxoSmithKline; Guardant Health; MSD Oncology; SERVIER; Takeda
(OPTIONAL) Uncompensated Relationships - Guardant Health
 
Jaffer Ajani
Honoraria - Acrotech Biopharma; Aduro Biotech; Amgen; Astellas Pharma; AstraZeneca; BeiGene; Boehringer Ingelheim; Bristol-Myers Squibb; Daiichi Sankyo; DAVA Pharmaceuticals; Fresenius Kabi; Gilead Sciences; GRAIL; Lilly; Merck; Novartis; oncotherics; SERVIER; zymeworks
Consulting or Advisory Role - American Cancer Society; Amgen; Astellas Pharma; BeiGene; BeiGene; Bristol-Myers Squibb; Geneos; Gilead Sciences; Jazz Pharmaceuticals; Kyowa Kirin International; Merck; Novartis; SERVIER; Vaccinogen; Zymeworks
Research Funding - Amgen; Astellas Pharma (Inst); Bristol-Myers Squibb; Daiichi Sankyo; Delta-Fly Pharma; Gilead Sciences; Lilly/ImClone; Merck; Novartis; ProLynx; Roche/Genentech; Taiho Pharmaceutical; Takeda; Zymeworks
Patents, Royalties, Other Intellectual Property - I have research funding from: Genentech, Roche, BMS, Taiho, MedImmune, Merck, Amgen, Lilly
 
Jin Gu
Employment - Gilead Sciences
Stock and Other Ownership Interests - Gilead Sciences
 
Daniel Koralek
Employment - Gilead Sciences
Stock and Other Ownership Interests - Gilead Sciences
 
Shivani Mhatre
Employment - Gilead Sciences
Stock and Other Ownership Interests - Gilead Sciences
 
Cosmina Hogea
Employment - Gilead Sciences
Stock and Other Ownership Interests - Gilead Sciences
 
Chloe Hammond
Employment - Adelphi
 
Katie Lewis
Employment - Adelphi